Thus, in CCM lesions, loss of CCM2 may reduce Rho degradation leading to hyperactivation of the ROCK pathway, however, despite the appeal of this model, no additional support has been reported in the decade since its initial publication. Here, CCM2 is linked to cerebral cavernous malformation.